Marie-Pascale Morin
Overview
Explore the profile of Marie-Pascale Morin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robichaud M, Morin M, Fecteau G, Buczinski S
JDS Commun
. 2024 Dec;
5(6):592-597.
PMID: 39650041
The objective of this cross-sectional observational study was to describe the transport conditions of calves at the time of their arrival at the 2 major livestock auction markets in the...
2.
Izarn O, Morin M, Ntobe-Bunkete B, Golbin L, Ferrand-Sorre M, Tron C, et al.
Ther Drug Monit
. 2024 Apr;
46(3):285-287.
PMID: 38648637
The authors described tacrolimus dosing in a kidney transplant patient concurrently treated with phenobarbital, where measuring the tacrolimus area under the curve was necessary to achieve adequate drug exposure and...
3.
Couette A, Tron C, Golbin L, Franck B, Houssel-Debry P, Frouget T, et al.
Eur J Clin Pharmacol
. 2023 Sep;
79(11):1549-1556.
PMID: 37725122
Purpose: Therapeutic drug monitoring of tacrolimus using trough concentration (C) is mandatory to ensure drug efficacy and safety in solid organ transplantation. However, C is just a proxy for the...
4.
Meuleman M, Vieira-Martins P, El Sissy C, Audard V, Baudouin V, Bertrand D, et al.
Clin J Am Soc Nephrol
. 2023 Aug;
18(11):1435-1445.
PMID: 37615951
Background: C3 glomerulopathy and idiopathic immunoglobulin-mediated membranoproliferative GN (Ig-MPGN) are rare complement-mediated kidney diseases. Inherited forms of C3 glomerulopathy/Ig-MPGN are rarely described. Methods: Three hundred ninety-eight patients with C3 glomerulopathy...
5.
Lhermitte R, Le Dare B, Laval F, Lemaitre F, Troussier B, Morin M, et al.
Eur J Hosp Pharm
. 2023 Feb;
31(4):314-320.
PMID: 36737230
Objectives: Given the positive impact of appropriate medication management on graft outcome and therefore of patient survival and graft function, the pharmacist's role in the kidney transplantation team has evolved...
6.
Courbebaisse M, Bourmaud A, Souberbielle J, Sberro-Soussan R, Moal V, Le Meur Y, et al.
Am J Transplant
. 2023 Jan;
23(3):366-376.
PMID: 36695682
Vitamin D sufficiency is associated with a reduced risk of fractures, diabetes mellitus, cardiovascular events, and cancers, which are frequent complications after renal transplantation. The VITALE (VITamin D supplementation in...
7.
Buczinski S, Morin M, Roy J, Rousseau M, Villettaz-Robichaud M, Dubuc J
J Dairy Sci
. 2021 Nov;
105(2):1638-1648.
PMID: 34802728
The objective of this observational cross-sectional study was to describe the cleanliness of various equipment used for colostrum harvest and calf feeding procedures on dairy farms in Québec, Canada. The...
8.
Meuleman M, Guilmin-Crepon S, Hummel A, Daugas E, Dumas A, Leye F, et al.
J Nephrol
. 2021 Jul;
35(4):1123-1134.
PMID: 34224090
Background: Long-term psychosocial outcomes and health-related quality of life (HRQOL) in adults with pediatric onset of frequently relapsing or steroid-dependent idiopathic nephrotic syndrome (FRNS or SDNS) remain to be determined....
9.
Lanaret C, Anglicheau D, Audard V, Buchler M, Caillard S, Couzi L, et al.
Am J Transplant
. 2021 Jan;
21(9):3021-3033.
PMID: 33512779
Rituximab (RTX) therapy for primary focal segmental glomerulosclerosis recurrence after kidney transplantation (KT) has been extensively debated. We aimed to assess the benefit of adding RTX to plasmapheresis (PP), corticosteroids,...
10.
Cornec-Le Gall E, Audrezet M, Rousseau A, Hourmant M, Renaudineau E, Charasse C, et al.
J Am Soc Nephrol
. 2015 Jul;
27(3):942-51.
PMID: 26150605
The course of autosomal dominant polycystic kidney disease (ADPKD) varies among individuals, with some reaching ESRD before 40 years of age and others never requiring RRT. In this study, we...